CVS Health CVS
$83.85 +$2.52 (+3.10%)
Market closed · Nov 7, 9:10 am ET · Last extended-hours $84.15 +0.36%
Open$80.70
Prev close$81.33
Day range$80.69 – $84.38
Volume16.10M
Market cap$107.28B
P/E (TTM)9.7
Dividend yield3.17%
CVS Stock News
Headlines matching CVS Health or the CVS ticker, most recent first.
- Wells Fargo Maintains CVS Health(CVS.US) With Buy Rating, Maintains Target Price $123
- Bernstein Maintains CVS Health(CVS.US) With Buy Rating, Maintains Target Price $106
- UBS Maintains CVS Health(CVS.US) With Buy Rating, Cuts Target Price to $118 Negative
- Barclays Maintains CVS GROUP PLC(CVSGF.US) With Buy Rating, Cuts Target Price to $21.16 Negative
- Jefferies Maintains CVS GROUP PLC(CVSGF.US) With Hold Rating, Raises Target Price to $18.55 Positive
- Company Q&A | Andon Health: The company's test kit products are currently available through sales channels including Amazon, CVS, and Walmart.
- Wells Fargo Maintains CVS Health(CVS.US) With Buy Rating, Maintains Target Price $123
- BofA Securities Maintains CVS Health(CVS.US) With Buy Rating, Maintains Target Price $120
- A Quick Look at Today's Ratings for CVS Health(CVS.US), With a Forecast Between $107 to $126
- Jefferies Maintains CVS Health(CVS.US) With Buy Rating, Raises Target Price to $120 Positive
- Piper Sandler Maintains CVS Health(CVS.US) With Buy Rating, Raises Target Price to $113 Positive
- TD Cowen Maintains CVS Health(CVS.US) With Buy Rating, Maintains Target Price $110
- Argus Research Maintains CVS Health(CVS.US) With Buy Rating, Raises Target Price to $114 Positive
- J.P. Morgan Remains a Buy on CVS Health (CVS)
- J.P. Morgan Maintains CVS Health(CVS.US) With Buy Rating, Announces Target Price $118
No comments yet — be the first to weigh in on CVS.
Sign in to join the discussion.